Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Purpose: Existing definitions of clinically important weight loss (WL) in patients with cancer are unclear and heterogeneous and do not consider current trends toward obesity. Methods: Canadian and European patients with cancer (n = 8,160) formed a population-based data set. Body mass index (BMI) and percent WL (%WL) were recorded, and patients were observed prospectively until death. Data were entered into a multivariable analysis controlling for age, sex, cancer site, stage, and performance status. Relationships for BMI and %WL to overall survival were examined to develop a grading system. Results: Mean overall %WL was −9.7% ± 8.4% and BMI was 24.4 ± 5.1 kg/m 2, and both %WL and BMI independently predicted survival (P < .01). Differences in survival were observed across five categories of BMI (< 20.0, 20.0 to 21.9, 22.0 to 24.9, 25.0 to 27.9, and ≥ 28.0 kg/m 2; P < .001) and five categories of %WL (−2.5% to −5.9%, −6.0% to −10.9%, −11.0% to −14.9%, ≥ −15.0%, and weight stable (± 2.4%); P < .001). A 5 × 5 matrix representing the five %WL categories within each of the five BMI categories was graded based on median survival and prognostic significance. Weight-stable patients with BMI ≥ 25.0 kg/m 2 (grade 0) had the longest survival (20.9 months; 95% CI, 17.9 to 23.9 months), and %WL values associated with lowered categories of BMI were related to shorter survival (P < .001), as follows: grade 1, 14.6 months (95% CI, 12.9 to 16.2 months); grade 2, 10.8 months (95% CI, 9.7 to 11.9 months); grade 3, 7.6 months (95% CI, 7.0 to 8.2 months); and grade 4, 4.3 months (95% CI, 4.1 to 4.6 months). Survival discrimination by grade was observed within specific cancers, stages, ages, and performance status and in an independent validation sample (n = 2,963). Conclusion: A robust grading system incorporating the independent prognostic significance of both BMI and %WL was developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Self-citationFlegal, K. M., Kit, B. K., Orpana, H., & Graubard, B. I. (2013) · JAMA · doi:10.1001/jama.2012.113905 · Cited by 3,998 · cited 1×
“Obesity is usually considered a disadvantage based on studies of all-cause mortality.(9) However, obesity confers a survival advantage in patients with several diseases associated with WL (eg, heart and renal failure).”
BackgroundPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Self-citationMartin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,680
Self-citationPrognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354
Pencina, M. J., & D'Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1802 · Cited by 1,444
Understanding the mechanisms and treatment options in cancer cachexia
Fearon, K., Arends, J., & Baracos, V. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.209 · Cited by 940
Self-citationFearon, K. C. H. (2003) · Gut · doi:10.1136/gut.52.10.1479 · Cited by 603
Self-citationNguyen, D. M., & El-Serag, H. B. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.12.014 · Cited by 531
Risk factor paradox in wasting diseases
Kalantar-Zadeh, K., Horwich, T. B., Oreopoulos, A., Kovesdy, C. P., Younessi, H., Anker, S. D., & Morley, J. E. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3281a30594 · Cited by 309
Cited by
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
Self-citationBaracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738
Self-citationESPEN expert group recommendations for action against cancer-related malnutrition
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E. P., Erickson, N., Laviano, A., Lisanti, M. P., Lobo, D. N., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.017 · Cited by 1,305
“In terms of poor health outcomes, malnutrition was associated with loss of weight and muscle [22], reduced immune competence and more infections [1,20,23], psychosocial stress [24], lower quality of life [25], treatment toxicity [19], and greater risk of mortality [1,21,22].”
BackgroundSelf-citationManagement of Cancer Cachexia: ASCO Guideline
Roeland, E. J., Bohlke, K., Baracos, V. E., Bruera, E., del Fabbro, E., Dixon, S., Fallon, M., Herrstedt, J., Lau, H., Platek, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00611 · Cited by 644
Self-citationRyan, A. M., Power, D. G., Daly, L., Cushen, S. J., Ní Bhuachalla, Ē., & Prado, C. M. (2016) · Proceedings of the Nutrition Society · doi:10.1017/s002966511500419x · Cited by 542
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study
Muscaritoli, M., the PreMiO Study Group, Lucia, S., Farcomeni, A., Lorusso, V., Saracino, V., Barone, C., Plastino, F., Gori, S., Magarotto, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20168 · Cited by 438
Ravasco, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081211 · Cited by 353
Ponsegromab for the Treatment of Cancer Cachexia
Groarke, J. D., Crawford, J., Collins, S. M., Lubaczewski, S., Roeland, E. J., Naito, T., Hendifar, A. E., Fallon, M., Takayama, K., Asmis, T., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2409515 · Cited by 319
Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact
Prado, C. M., Cushen, S. J., Orsso, C. E., & Ryan, A. M. (2016) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115004279 · Cited by 300
Influence of body composition profile on outcomes following colorectal cancer surgery
Malietzis, G., Currie, A. C., Athanasiou, T., Johns, N., Anyamene, N., Glynne-Jones, R., Kennedy, R. H., Fearon, K. C. H., & Jenkins, J. T. (2016) · British Journal of Surgery · doi:10.1002/bjs.10075 · Cited by 299
Self-citationCancer Cachexia: Definition, Staging, and Emerging Treatments
Ni, J., & Zhang, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s261585 · Cited by 290
Cachexia in patients with oesophageal cancer
Anandavadivelan, P., & Lagergren, P. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.200 · Cited by 262
Argilés, J. M., López-Soriano, F. J., Stemmler, B., & Busquets, S. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00734-5 · Cited by 246
Cancer Cachexia: Its Mechanism and Clinical Significance
Nishikawa, H., Goto, M., Fukunishi, S., Asai, A., Nishiguchi, S., & Higuchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168491 · Cited by 233
“Prevention of weight loss by early intervention may also lead to continuation of cancer treatment and favorable prognosis [14,19,21,32].”
BackgroundInfluentialCancer-induced muscle wasting: latest findings in prevention and treatment
Aversa, Z., Costelli, P., & Muscaritoli, M. (2017) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017698643 · Cited by 215
Prehabilitation and Nutritional Support to Improve Perioperative Outcomes
West, M. A., Wischmeyer, P. E., & Grocott, M. P. W. (2017) · Current Anesthesiology Reports · doi:10.1007/s40140-017-0245-2 · Cited by 169
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients
Ubachs, J., Ziemons, J., Soons, Z., Aarnoutse, R., van Dijk, D. P. J., Penders, J., van Helvoort, A., Smidt, M. L., Kruitwagen, R. F. P. M., Baade‐Corpelijn, L., et al. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12804 · Cited by 161
“Figure S2.”
BackgroundMethodInfluentialNaumann, P., Eberlein, J., Farnia, B., Liermann, J., Hackert, T., Debus, J., & Combs, S. E. (2019) · Cancers · doi:10.3390/cancers11111655 · Cited by 54
“4% reflecting diurnal variation as previously described [26].”
MethodNishie, K., Yamamoto, S., Nagata, C., Koizumi, T., & Hanaoka, M. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.07.023 · Cited by 52
Guerdoux-Ninot, E., Flori, N., Janiszewski, C., Vaillé, A., de Forges, H., Raynard, B., Baracos, V. E., Thezenas, S., & Senesse, P. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.06.974 · Cited by 40
Self-citationCurrow, D. C., Maddocks, M., Cella, D., & Muscaritoli, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113471 · Cited by 27
“The more accentuated the weight loss and the more rapid the decrease in BMI, the stronger the correlation with higher morbidity and mortality [9].”
BackgroundOncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO)
Muscaritoli, M., Bar-Sela, G., Battisti, N. M. L., Belev, B., Contreras-Martínez, J., Cortesi, E., de Brito-Ashurst, I., Prado, C. M., Ravasco, P., & Yalcin, S. (2023) · Cancers · doi:10.3390/cancers15020380 · Cited by 23
“Indeed, since unintentional weight loss in patients with cancer has been shown to independently predict reduced survival [49], evaluation of the change in body weight was recommended for all patients (regardless of body weight or body mass index) at the time of diagnosis and throughout treatment.”
BackgroundRosa-Caldwell, M. E., Benson, C. A., Lee, D. E., Brown, J. L., Washington, T. A., Greene, N. P., & Wiggs, M. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217841 · Cited by 13
Muresan, B. T., Sánchez Juan, C., Artero, A., Montoro, A., Hernández Machancoses, A., Ruiz Berjaga, Y., Ríos Ríos, J., Soriano del Castillo, J. M., Sebastià Fabregat, N., Prieto Colodrero, N., et al. (2019) · Revista Española de Nutrición Humana y Dietética · doi:10.14306/renhyd.23.3.724 · Cited by 1
Metadata
- Authors
- Martin, L., Senesse, P., Gioulbasanis, I., Antoun, S., Bozzetti, F., Deans, C., Strasser, F., Thoresen, L., Jagoe, R. T., Chasen, M., Lundholm, K., Bosaeus, I., Fearon, K. H., & Baracos, V. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-01-01
- Volume
- 33
- Issue
- 1
- Pages
- 90-99
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2121911732
- Cited by
- 798
- References
- 31
- FWCI
- 19.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.